The more dominant immune subsets in the tumor were: the naïve CD4 T cells, regulatory T cells, activated dendritic cells, resting mast cells, M0 macrophages, and CD49a NK cells (Table 2). This evidence concerns the gene ITGA1 and neoplasm.